![Jeff Boyle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeff Boyle
Investor Relations Contact bij
ARVINAS, INC.
Profiel
Jeff Boyle is Vice President-Investor Relations at Arvinas, Inc. since 2021.
Formerly, Mr. Boyle was Vice President-Investor Relations at SAGE Therapeutics, Inc. from 2017 to 2021 and Senior Director-Corporate & Investor Relations at DNIB Unwind, Inc. from 2014 to 2016.
Education includes undergraduate studies at The University of Colorado.
Actieve functies van Jeff Boyle
| Bedrijven | Functie | Begin |
|---|---|---|
| ARVINAS, INC. | Investor Relations Contact | 01-09-2021 |
Eerdere bekende functies van Jeff Boyle
| Bedrijven | Functie | Einde |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Investor Relations Contact | 01-09-2021 |
| DNIB UNWIND INC | Investor Relations Contact | 30-11-2016 |
Opleiding van Jeff Boyle
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
57
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations | Health Technology |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
